| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 8.66e-08 | 188 | 83 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 9.13e-07 | 323 | 83 | 10 | GO:1901681 | |
| GeneOntologyMolecularFunction | heparin binding | 1.35e-06 | 192 | 83 | 8 | GO:0008201 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.71e-06 | 268 | 83 | 9 | GO:0005539 | |
| GeneOntologyMolecularFunction | growth factor binding | 3.92e-06 | 156 | 83 | 7 | GO:0019838 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 5.98e-05 | 51 | 83 | 4 | GO:0043394 | |
| GeneOntologyMolecularFunction | calcium ion binding | PLSCR4 SLIT2 NELL1 NELL2 MEGF8 SLIT1 PLA2G2A CBLC VWCE LRP1B AGRN EGFL6 | 5.98e-05 | 749 | 83 | 12 | GO:0005509 |
| GeneOntologyMolecularFunction | integrin binding | 8.98e-05 | 175 | 83 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 2.34e-04 | 29 | 83 | 3 | GO:0043395 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 4.35e-04 | 85 | 83 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 9.24e-04 | 46 | 83 | 3 | GO:0030020 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 9.64e-04 | 105 | 83 | 4 | GO:0004867 | |
| GeneOntologyMolecularFunction | Roundabout binding | 1.10e-03 | 12 | 83 | 2 | GO:0048495 | |
| GeneOntologyMolecularFunction | tumor necrosis factor receptor activity | 1.10e-03 | 12 | 83 | 2 | GO:0005031 | |
| GeneOntologyMolecularFunction | vascular endothelial growth factor receptor binding | 2.23e-03 | 17 | 83 | 2 | GO:0005172 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 2.79e-03 | 19 | 83 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | death receptor activity | 3.41e-03 | 21 | 83 | 2 | GO:0005035 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 3.49e-03 | 73 | 83 | 3 | GO:0050840 | |
| GeneOntologyMolecularFunction | BMP binding | 3.74e-03 | 22 | 83 | 2 | GO:0036122 | |
| GeneOntologyMolecularFunction | structural molecule activity | 3.79e-03 | 891 | 83 | 10 | GO:0005198 | |
| GeneOntologyMolecularFunction | zinc ion binding | TRIM45 ADAMDEC1 POLA1 TADA2B CBLC KMT2A BIRC2 KDM1B SUV39H2 TET3 | 3.79e-03 | 891 | 83 | 10 | GO:0008270 |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | 4.06e-03 | 616 | 83 | 8 | GO:0030545 | |
| GeneOntologyMolecularFunction | cytokine binding | 4.18e-03 | 157 | 83 | 4 | GO:0019955 | |
| GeneOntologyMolecularFunction | iron-sulfur cluster binding | 4.21e-03 | 78 | 83 | 3 | GO:0051536 | |
| GeneOntologyMolecularFunction | DNA-directed DNA polymerase activity | 4.81e-03 | 25 | 83 | 2 | GO:0003887 | |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 4.84e-03 | 82 | 83 | 3 | GO:1990756 | |
| GeneOntologyMolecularFunction | metal cluster binding | 5.01e-03 | 83 | 83 | 3 | GO:0051540 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 5.20e-03 | 26 | 83 | 2 | GO:0050431 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 1.16e-05 | 124 | 84 | 6 | GO:0007229 | |
| GeneOntologyBiologicalProcess | response to growth factor | VEGFC COL2A1 SLIT2 SPRY3 IGF1R CHRDL2 MEGF8 PCSK6 WFIKKN2 CBLC KMT2A CCN2 ITGB8 VEGFB | 1.22e-05 | 883 | 84 | 14 | GO:0070848 |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | VEGFC COL2A1 SLIT2 SPRY3 IGF1R CHRDL2 MEGF8 PCSK6 WFIKKN2 KMT2A CCN2 ITGB8 VEGFB | 3.76e-05 | 850 | 84 | 13 | GO:0071363 |
| GeneOntologyBiologicalProcess | epigenetic programming in the zygotic pronuclei | 4.25e-05 | 17 | 84 | 3 | GO:0044725 | |
| GeneOntologyBiologicalProcess | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration | 4.90e-05 | 3 | 84 | 2 | GO:0021834 | |
| GeneOntologyBiologicalProcess | regulation of response to external stimulus | VEGFC TRIM45 SLIT2 PJA2 IGF1R MEGF8 SPAAR SLIT1 PLA2G2A BIRC2 PLAT GRN TNFRSF11A AGRN GP5 VEGFB | 7.10e-05 | 1316 | 84 | 16 | GO:0032101 |
| GeneOntologyBiologicalProcess | granulocyte activation | 9.18e-05 | 58 | 84 | 4 | GO:0036230 | |
| GeneOntologyBiologicalProcess | axon extension involved in axon guidance | 9.49e-05 | 22 | 84 | 3 | GO:0048846 | |
| GeneOntologyBiologicalProcess | neuron projection extension involved in neuron projection guidance | 9.49e-05 | 22 | 84 | 3 | GO:1902284 | |
| GeneOntologyBiologicalProcess | dorsal/ventral axon guidance | 9.78e-05 | 4 | 84 | 2 | GO:0033563 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | SPRY3 PJA2 IGF1R PRAMEF5 TENM1 PLA2G2A CBLC CCN2 TNFRSF11A FAS PRAMEF6 VEGFB | 1.11e-04 | 815 | 84 | 12 | GO:0043408 |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 1.17e-04 | 270 | 84 | 7 | GO:0007160 | |
| GeneOntologyBiologicalProcess | embryonic olfactory bulb interneuron precursor migration | 1.63e-04 | 5 | 84 | 2 | GO:0021831 | |
| GeneOntologyBiologicalProcess | positive regulation of response to external stimulus | VEGFC SLIT2 PJA2 IGF1R MEGF8 PLA2G2A BIRC2 PLAT GRN TNFRSF11A VEGFB | 1.97e-04 | 738 | 84 | 11 | GO:0032103 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 2.66e-04 | 410 | 84 | 8 | GO:0031589 | |
| GeneOntologyBiologicalProcess | positive regulation of mast cell chemotaxis | 3.40e-04 | 7 | 84 | 2 | GO:0060754 | |
| GeneOntologyBiologicalProcess | MAPK cascade | SPRY3 PJA2 IGF1R PRAMEF5 TENM1 PLA2G2A CBLC CCN2 TNFRSF11A FAS PRAMEF6 VEGFB | 3.73e-04 | 930 | 84 | 12 | GO:0000165 |
| GeneOntologyBiologicalProcess | plasma lipoprotein particle remodeling | 4.22e-04 | 36 | 84 | 3 | GO:0034369 | |
| GeneOntologyBiologicalProcess | protein-lipid complex remodeling | 4.22e-04 | 36 | 84 | 3 | GO:0034368 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 4.27e-04 | 334 | 84 | 7 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 4.27e-04 | 334 | 84 | 7 | GO:0001894 | |
| GeneOntologyBiologicalProcess | regulation of neutrophil activation | 4.52e-04 | 8 | 84 | 2 | GO:1902563 | |
| GeneOntologyBiologicalProcess | regulation of chemotaxis | 4.64e-04 | 242 | 84 | 6 | GO:0050920 | |
| GeneOntologyBiologicalProcess | protein-containing complex remodeling | 5.36e-04 | 39 | 84 | 3 | GO:0034367 | |
| GeneOntologyBiologicalProcess | positive regulation of response to wounding | 5.67e-04 | 93 | 84 | 4 | GO:1903036 | |
| GeneOntologyBiologicalProcess | cellular response to zinc ion starvation | 5.79e-04 | 9 | 84 | 2 | GO:0034224 | |
| GeneOntologyBiologicalProcess | response to zinc ion starvation | 5.79e-04 | 9 | 84 | 2 | GO:0120127 | |
| GeneOntologyBiologicalProcess | regulation of mast cell chemotaxis | 5.79e-04 | 9 | 84 | 2 | GO:0060753 | |
| GeneOntologyCellularComponent | extracellular matrix | COL2A1 SLIT2 COL6A3 ZAN ADAMDEC1 OTOGL PCSK6 LAMA2 COL6A5 PLAT CCN2 NYX TECTA MUC2 PRG4 AGRN EGFL6 | 9.90e-10 | 656 | 85 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL2A1 SLIT2 COL6A3 ZAN ADAMDEC1 OTOGL PCSK6 LAMA2 COL6A5 PLAT CCN2 NYX TECTA MUC2 PRG4 AGRN EGFL6 | 1.04e-09 | 658 | 85 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL2A1 SLIT2 COL6A3 ADAMDEC1 PCSK6 LAMA2 COL6A5 PLAT CCN2 MUC2 PRG4 AGRN EGFL6 | 2.16e-07 | 530 | 85 | 13 | GO:0062023 |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 9.77e-05 | 59 | 85 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | sarcolemma | 1.26e-04 | 190 | 85 | 6 | GO:0042383 | |
| GeneOntologyCellularComponent | nuclear matrix | 2.68e-04 | 140 | 85 | 5 | GO:0016363 | |
| GeneOntologyCellularComponent | integrin complex | 2.96e-04 | 32 | 85 | 3 | GO:0008305 | |
| GeneOntologyCellularComponent | nuclear periphery | 6.68e-04 | 171 | 85 | 5 | GO:0034399 | |
| GeneOntologyCellularComponent | membrane raft | 6.83e-04 | 362 | 85 | 7 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 7.06e-04 | 364 | 85 | 7 | GO:0098857 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.02e-03 | 109 | 85 | 4 | GO:0005796 | |
| GeneOntologyCellularComponent | basement membrane | 1.55e-03 | 122 | 85 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | cell surface | SLIT2 ADAM20 PCSK6 SCN5A PLAT TNFRSF11A FAS ITGB2 AGRN ITGB7 ITGB8 GP5 | 1.74e-03 | 1111 | 85 | 12 | GO:0009986 |
| MousePheno | joint swelling | 3.01e-06 | 7 | 63 | 3 | MP:0002936 | |
| MousePheno | abnormal hyaline cartilage morphology | 5.30e-05 | 46 | 63 | 4 | MP:0006429 | |
| MousePheno | increased dendritic spine number | 5.98e-05 | 3 | 63 | 2 | MP:0021019 | |
| Domain | EGF-like_dom | PCSK5 SLIT2 NELL1 NELL2 ZAN MEGF8 SCARF2 ADAM20 PCSK6 SLIT1 TENM1 LAMA2 PLAT ADAM32 TECTA C9 VWCE LRP1B AGRN EGFL6 PEAR1 | 1.20e-21 | 249 | 81 | 21 | IPR000742 |
| Domain | EGF_1 | SLIT2 NELL1 NELL2 ZAN MEGF8 SCARF2 ADAM20 SLIT1 TENM1 LAMA2 PLAT ADAM32 C9 VWCE LRP1B ITGB2 AGRN ITGB7 ITGB8 EGFL6 PEAR1 | 1.98e-21 | 255 | 81 | 21 | PS00022 |
| Domain | EGF-like_CS | SLIT2 NELL1 NELL2 ZAN MEGF8 SCARF2 ADAM20 SLIT1 TENM1 LAMA2 PLAT ADAM32 C9 VWCE LRP1B ITGB2 AGRN ITGB7 ITGB8 EGFL6 PEAR1 | 3.24e-21 | 261 | 81 | 21 | IPR013032 |
| Domain | EGF_2 | SLIT2 NELL1 NELL2 ZAN MEGF8 SCARF2 ADAM20 SLIT1 TENM1 LAMA2 PLAT ADAM32 C9 VWCE LRP1B ITGB2 AGRN ITGB7 ITGB8 EGFL6 PEAR1 | 4.46e-21 | 265 | 81 | 21 | PS01186 |
| Domain | EGF | PCSK5 SLIT2 NELL1 NELL2 ZAN MEGF8 SCARF2 PCSK6 SLIT1 TENM1 LAMA2 PLAT ADAM32 TECTA VWCE LRP1B AGRN ITGB8 EGFL6 PEAR1 | 1.04e-20 | 235 | 81 | 20 | SM00181 |
| Domain | EGF_3 | SLIT2 NELL1 NELL2 ZAN MEGF8 SCARF2 ADAM20 SLIT1 TENM1 PLAT ADAM32 C9 VWCE LRP1B AGRN EGFL6 PEAR1 | 1.75e-16 | 235 | 81 | 17 | PS50026 |
| Domain | VWC | 5.05e-14 | 38 | 81 | 9 | SM00214 | |
| Domain | VWFC_2 | 5.05e-14 | 38 | 81 | 9 | PS50184 | |
| Domain | Growth_fac_rcpt_ | PCSK5 NELL1 NELL2 IGF1R MEGF8 SCARF2 PCSK6 SLIT1 CCN2 C9 VWCE LRP1B EGFL6 | 1.34e-13 | 156 | 81 | 13 | IPR009030 |
| Domain | VWF_dom | 1.36e-13 | 42 | 81 | 9 | IPR001007 | |
| Domain | VWFC_1 | 2.41e-12 | 36 | 81 | 8 | PS01208 | |
| Domain | EGF_extracell | 4.25e-12 | 60 | 81 | 9 | IPR013111 | |
| Domain | EGF_2 | 4.25e-12 | 60 | 81 | 9 | PF07974 | |
| Domain | VWC_out | 1.43e-10 | 19 | 81 | 6 | SM00215 | |
| Domain | VWC | 1.92e-09 | 28 | 81 | 6 | PF00093 | |
| Domain | EGF_CA | 2.82e-09 | 122 | 81 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.26e-09 | 124 | 81 | 9 | IPR001881 | |
| Domain | EGF_Ca-bd_CS | 9.30e-09 | 97 | 81 | 8 | IPR018097 | |
| Domain | EGF_CA | 1.09e-08 | 99 | 81 | 8 | PS01187 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.88e-08 | 106 | 81 | 8 | IPR000152 | |
| Domain | LamG | 3.41e-08 | 44 | 81 | 6 | SM00282 | |
| Domain | Integin_beta_N | 4.07e-08 | 9 | 81 | 4 | IPR033760 | |
| Domain | PSI_integrin | 4.07e-08 | 9 | 81 | 4 | PF17205 | |
| Domain | Laminin_G | 1.86e-07 | 58 | 81 | 6 | IPR001791 | |
| Domain | ASX_HYDROXYL | 2.56e-07 | 100 | 81 | 7 | PS00010 | |
| Domain | Laminin_EGF | 3.97e-07 | 35 | 81 | 5 | PF00053 | |
| Domain | EGF_Lam | 3.97e-07 | 35 | 81 | 5 | SM00180 | |
| Domain | ConA-like_dom | 4.46e-07 | 219 | 81 | 9 | IPR013320 | |
| Domain | Laminin_EGF | 6.07e-07 | 38 | 81 | 5 | IPR002049 | |
| Domain | Laminin_G_2 | 7.91e-07 | 40 | 81 | 5 | PF02210 | |
| Domain | CTCK_1 | 9.59e-07 | 18 | 81 | 4 | PS01185 | |
| Domain | EGF | 1.24e-06 | 126 | 81 | 7 | PF00008 | |
| Domain | EGF_CA | 1.97e-06 | 86 | 81 | 6 | PF07645 | |
| Domain | CT | 2.26e-06 | 22 | 81 | 4 | SM00041 | |
| Domain | - | 3.52e-06 | 95 | 81 | 6 | 2.60.120.200 | |
| Domain | Cys_knot_C | 3.87e-06 | 25 | 81 | 4 | IPR006207 | |
| Domain | CTCK_2 | 3.87e-06 | 25 | 81 | 4 | PS01225 | |
| Domain | Integrin_beta | 4.33e-06 | 8 | 81 | 3 | PF00362 | |
| Domain | INB | 4.33e-06 | 8 | 81 | 3 | SM00187 | |
| Domain | Integrin_bsu_VWA | 4.33e-06 | 8 | 81 | 3 | IPR002369 | |
| Domain | Integrin_bsu | 6.48e-06 | 9 | 81 | 3 | IPR015812 | |
| Domain | INTEGRIN_BETA | 6.48e-06 | 9 | 81 | 3 | PS00243 | |
| Domain | Fol_N | 1.26e-05 | 11 | 81 | 3 | IPR003645 | |
| Domain | Laminin_G_1 | 1.26e-05 | 11 | 81 | 3 | PF00054 | |
| Domain | FOLN | 1.26e-05 | 11 | 81 | 3 | SM00274 | |
| Domain | TIL | 1.68e-05 | 12 | 81 | 3 | PF01826 | |
| Domain | C8 | 1.68e-05 | 12 | 81 | 3 | PF08742 | |
| Domain | - | 1.73e-05 | 74 | 81 | 5 | 3.40.50.410 | |
| Domain | LAM_G_DOMAIN | 2.17e-05 | 38 | 81 | 4 | PS50025 | |
| Domain | Unchr_dom_Cys-rich | 2.18e-05 | 13 | 81 | 3 | IPR014853 | |
| Domain | C8 | 2.18e-05 | 13 | 81 | 3 | SM00832 | |
| Domain | TIL_dom | 2.76e-05 | 14 | 81 | 3 | IPR002919 | |
| Domain | VWFA | 2.84e-05 | 82 | 81 | 5 | PS50234 | |
| Domain | VWA | 3.20e-05 | 84 | 81 | 5 | SM00327 | |
| Domain | PSI | 3.91e-05 | 44 | 81 | 4 | IPR016201 | |
| Domain | VWD | 4.23e-05 | 16 | 81 | 3 | SM00216 | |
| Domain | WAP | 4.23e-05 | 16 | 81 | 3 | SM00217 | |
| Domain | VWF_type-D | 4.23e-05 | 16 | 81 | 3 | IPR001846 | |
| Domain | MAM_1 | 4.23e-05 | 16 | 81 | 3 | PS00740 | |
| Domain | VWFD | 4.23e-05 | 16 | 81 | 3 | PS51233 | |
| Domain | WAP | 4.23e-05 | 16 | 81 | 3 | PF00095 | |
| Domain | VWD | 4.23e-05 | 16 | 81 | 3 | PF00094 | |
| Domain | PSI | 4.66e-05 | 46 | 81 | 4 | SM00423 | |
| Domain | WAP | 5.11e-05 | 17 | 81 | 3 | PS51390 | |
| Domain | - | 5.11e-05 | 17 | 81 | 3 | 4.10.75.10 | |
| Domain | MAM | 5.11e-05 | 17 | 81 | 3 | SM00137 | |
| Domain | - | 5.56e-05 | 3 | 81 | 2 | 3.90.1600.10 | |
| Domain | DNA_pol_palm_dom | 5.56e-05 | 3 | 81 | 2 | IPR023211 | |
| Domain | TILa | 5.56e-05 | 3 | 81 | 2 | PF12714 | |
| Domain | DNA_POLYMERASE_B | 5.56e-05 | 3 | 81 | 2 | PS00116 | |
| Domain | TILa_dom | 5.56e-05 | 3 | 81 | 2 | IPR025615 | |
| Domain | CSRNP_N | 5.56e-05 | 3 | 81 | 2 | IPR031972 | |
| Domain | CSRNP_N | 5.56e-05 | 3 | 81 | 2 | PF16019 | |
| Domain | DNA-dir_DNA_pol_B_CS | 5.56e-05 | 3 | 81 | 2 | IPR017964 | |
| Domain | Cys/Ser-rich_nuc_prot | 5.56e-05 | 3 | 81 | 2 | IPR023260 | |
| Domain | MAM | 6.12e-05 | 18 | 81 | 3 | PF00629 | |
| Domain | MAM_dom | 6.12e-05 | 18 | 81 | 3 | IPR000998 | |
| Domain | MAM_2 | 6.12e-05 | 18 | 81 | 3 | PS50060 | |
| Domain | Furin_repeat | 6.12e-05 | 18 | 81 | 3 | IPR006212 | |
| Domain | - | 6.12e-05 | 18 | 81 | 3 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 6.12e-05 | 18 | 81 | 3 | IPR020901 | |
| Domain | FU | 6.12e-05 | 18 | 81 | 3 | SM00261 | |
| Domain | KU | 6.12e-05 | 18 | 81 | 3 | SM00131 | |
| Domain | VWF_A | 7.04e-05 | 99 | 81 | 5 | IPR002035 | |
| Domain | BPTI_KUNITZ_2 | 7.24e-05 | 19 | 81 | 3 | PS50279 | |
| Domain | Kunitz_BPTI | 7.24e-05 | 19 | 81 | 3 | PF00014 | |
| Domain | BPTI_KUNITZ_1 | 7.24e-05 | 19 | 81 | 3 | PS00280 | |
| Domain | Disintegrin | 9.88e-05 | 21 | 81 | 3 | PF00200 | |
| Domain | DISIN | 9.88e-05 | 21 | 81 | 3 | SM00050 | |
| Domain | DNA-dir_DNA_pol_B | 1.11e-04 | 4 | 81 | 2 | IPR006172 | |
| Domain | DNA-dir_DNA_pol_B_exonuc | 1.11e-04 | 4 | 81 | 2 | IPR006133 | |
| Domain | DNA-dir_DNA_pol_B_multi_dom | 1.11e-04 | 4 | 81 | 2 | IPR006134 | |
| Domain | DNA_pol_B_exo1 | 1.11e-04 | 4 | 81 | 2 | PF03104 | |
| Domain | DNA_pol_B | 1.11e-04 | 4 | 81 | 2 | PF00136 | |
| Domain | POLBc | 1.11e-04 | 4 | 81 | 2 | SM00486 | |
| Domain | WAP_dom | 1.14e-04 | 22 | 81 | 3 | IPR008197 | |
| Domain | Kunitz_BPTI | 1.31e-04 | 23 | 81 | 3 | IPR002223 | |
| Domain | Integrin_dom | 1.69e-04 | 25 | 81 | 3 | IPR032695 | |
| Domain | Integrin_bsu_cyt_dom | 2.76e-04 | 6 | 81 | 2 | IPR014836 | |
| Domain | GF_recep_IV | 2.76e-04 | 6 | 81 | 2 | PF14843 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.79e-08 | 84 | 56 | 7 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.12e-08 | 85 | 56 | 7 | M16441 | |
| Pathway | KEGG_FOCAL_ADHESION | 7.93e-08 | 199 | 56 | 9 | M7253 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 5.27e-07 | 76 | 56 | 6 | MM14867 | |
| Pathway | WP_FOCAL_ADHESION | 6.80e-07 | 187 | 56 | 8 | MM15913 | |
| Pathway | WP_FOCAL_ADHESION | 1.09e-06 | 199 | 56 | 8 | M39402 | |
| Pathway | WP_PI3KAKT_SIGNALING | 6.77e-06 | 339 | 56 | 9 | M39736 | |
| Pathway | REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO | 6.99e-06 | 10 | 56 | 3 | M27348 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.23e-05 | 76 | 56 | 5 | M27219 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL2A1 SLIT2 COL6A3 NELL2 SLIT1 SCN5A LAMA2 KIF4A COL6A5 KIF4B AGRN | 1.32e-05 | 575 | 56 | 11 | M29853 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.23e-05 | 42 | 56 | 4 | M7169 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.24e-05 | 300 | 56 | 8 | M610 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 2.35e-05 | 302 | 56 | 8 | M39719 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.51e-05 | 47 | 56 | 4 | MM14925 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 3.58e-05 | 418 | 56 | 9 | MM15587 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | VEGFC COL2A1 PCSK5 COL6A3 IGF1R PCSK6 LAMA2 COL6A5 PLAT VEGFB | 4.01e-05 | 532 | 56 | 10 | M27870 |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 4.06e-05 | 326 | 56 | 8 | MM15917 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 6.45e-05 | 20 | 56 | 3 | MM15061 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 6.84e-05 | 258 | 56 | 7 | MM14572 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 7.54e-05 | 57 | 56 | 4 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 8.08e-05 | 58 | 56 | 4 | M2049 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.12e-04 | 63 | 56 | 4 | M11187 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 1.15e-04 | 121 | 56 | 5 | M39823 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 1.45e-04 | 26 | 56 | 3 | M47 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 2.85e-04 | 325 | 56 | 7 | M12868 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL2A1 SLIT2 COL6A3 NELL2 MED16 PCSK6 SLIT1 SCN5A LAMA2 KMT2A KIF4A COL6A5 KIF4B TET3 AGRN | 3.43e-04 | 1432 | 56 | 15 | M509 |
| Pathway | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | 4.27e-04 | 8 | 56 | 2 | M710 | |
| Pathway | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | 4.27e-04 | 8 | 56 | 2 | MM14753 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 4.54e-04 | 38 | 56 | 3 | MM14969 | |
| Pathway | WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA | 5.48e-04 | 9 | 56 | 2 | M39670 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 5.69e-04 | 261 | 56 | 6 | MM15676 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 5.69e-04 | 41 | 56 | 3 | MM15538 | |
| Pathway | PID_AMB2_NEUTROPHILS_PATHWAY | 5.69e-04 | 41 | 56 | 3 | M159 | |
| Pathway | PID_VEGF_VEGFR_PATHWAY | 6.83e-04 | 10 | 56 | 2 | M137 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 7.01e-04 | 44 | 56 | 3 | M27812 | |
| Pathway | WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER | 7.99e-04 | 46 | 56 | 3 | M46466 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 8.21e-04 | 106 | 56 | 4 | M42535 | |
| Pathway | REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES | 8.33e-04 | 11 | 56 | 2 | MM15559 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 8.51e-04 | 47 | 56 | 3 | M39829 | |
| Pathway | WP_SPINAL_CORD_INJURY | 8.81e-04 | 108 | 56 | 4 | MM15954 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.02e-03 | 50 | 56 | 3 | MM14796 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 1.18e-03 | 13 | 56 | 2 | M1462 | |
| Pathway | WP_SPINAL_CORD_INJURY | 1.19e-03 | 117 | 56 | 4 | M39341 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.21e-03 | 53 | 56 | 3 | MM14566 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.65e-03 | 59 | 56 | 3 | M27218 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 1.68e-03 | 439 | 56 | 7 | M42563 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.82e-03 | 61 | 56 | 3 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.82e-03 | 61 | 56 | 3 | MM14637 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS | 1.99e-03 | 63 | 56 | 3 | M39884 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION | 1.99e-03 | 63 | 56 | 3 | M39646 | |
| Pathway | PID_INTEGRIN5_PATHWAY | 2.03e-03 | 17 | 56 | 2 | M212 | |
| Pathway | REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY | 2.03e-03 | 17 | 56 | 2 | M27561 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.08e-03 | 64 | 56 | 3 | M26953 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.28e-03 | 66 | 56 | 3 | M18 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION | 2.28e-03 | 66 | 56 | 3 | MM15875 | |
| Pathway | REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY | 2.28e-03 | 18 | 56 | 2 | MM15275 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.38e-03 | 67 | 56 | 3 | M26999 | |
| Pathway | REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES | 2.54e-03 | 19 | 56 | 2 | M27839 | |
| Pathway | SA_CASPASE_CASCADE | 2.54e-03 | 19 | 56 | 2 | M7997 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 2.81e-03 | 20 | 56 | 2 | MM1374 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 3.15e-03 | 74 | 56 | 3 | M16376 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 3.15e-03 | 74 | 56 | 3 | M39462 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 3.15e-03 | 74 | 56 | 3 | M160 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 3.40e-03 | 76 | 56 | 3 | MM14573 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_ATTACHMENT_AND_ENTRY | 3.72e-03 | 23 | 56 | 2 | M48234 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 3.72e-03 | 23 | 56 | 2 | M47537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 3.72e-03 | 23 | 56 | 2 | M47720 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 4.36e-03 | 83 | 56 | 3 | M8728 | |
| Pathway | WP_APOPTOSIS | 4.36e-03 | 83 | 56 | 3 | MM15972 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY | 4.36e-03 | 83 | 56 | 3 | M47961 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_REMODELING | 4.39e-03 | 25 | 56 | 2 | MM15562 | |
| Pubmed | 5.34e-10 | 118 | 85 | 8 | 21078624 | ||
| Pubmed | 3.65e-08 | 38 | 85 | 5 | 25572963 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.79e-07 | 248 | 85 | 8 | 24006456 | |
| Pubmed | Depletion of VGLL4 Causes Perinatal Lethality without Affecting Myocardial Development. | 1.67e-06 | 10 | 85 | 3 | 36139407 | |
| Pubmed | 3.35e-06 | 257 | 85 | 7 | 16335952 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 4.18e-06 | 97 | 85 | 5 | 27559042 | |
| Pubmed | 4.59e-06 | 45 | 85 | 4 | 22696295 | ||
| Pubmed | 4.69e-06 | 175 | 85 | 6 | 28071719 | ||
| Pubmed | KIF4 regulates neuronal morphology and seizure susceptibility via the PARP1 signaling pathway. | 5.90e-06 | 2 | 85 | 2 | 36482480 | |
| Pubmed | The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential. | 5.90e-06 | 2 | 85 | 2 | 30081192 | |
| Pubmed | COL6A and LAMA2 Mutation Congenital Muscular Dystrophy: A Clinical and Electrophysiological Study. | 5.90e-06 | 2 | 85 | 2 | 29465610 | |
| Pubmed | Chromokinesin Kif4 promotes proper anaphase in mouse oocyte meiosis. | 5.90e-06 | 2 | 85 | 2 | 31067151 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 10548494 | ||
| Pubmed | Cellular motor protein KIF-4 associates with retroviral Gag. | 5.90e-06 | 2 | 85 | 2 | 10559369 | |
| Pubmed | Expression of Pla2g2a prevents carcinogenesis in Muc2-deficient mice. | 5.90e-06 | 2 | 85 | 2 | 19037975 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22157752 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21565503 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 16103356 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22335030 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 7929562 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 25726761 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 29458143 | ||
| Pubmed | Whole genome expression microarray reveals novel roles for Kif4 in monocyte/macrophage cells. | 5.90e-06 | 2 | 85 | 2 | 31486502 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12515855 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 10773663 | ||
| Pubmed | Specificity of MLL1 and TET3 CXXC domains towards naturally occurring cytosine modifications. | 5.90e-06 | 2 | 85 | 2 | 30352306 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 10231576 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 18061232 | ||
| Pubmed | Slit proteins: molecular guidance cues for cells ranging from neurons to leukocytes. | 5.90e-06 | 2 | 85 | 2 | 12200164 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 31616463 | ||
| Pubmed | Connective tissue growth factor regulates fibrosis-associated renal lymphangiogenesis. | 5.90e-06 | 2 | 85 | 2 | 28545716 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 28350061 | ||
| Pubmed | Directional guidance of neuronal migration in the olfactory system by the protein Slit. | 5.90e-06 | 2 | 85 | 2 | 10432110 | |
| Pubmed | Kif4 interacts with EB1 and stabilizes microtubules downstream of Rho-mDia in migrating fibroblasts. | 5.90e-06 | 2 | 85 | 2 | 24658398 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8335106 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8468318 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23320558 | ||
| Pubmed | Slit1 and slit2 proteins control the development of the lateral olfactory tract. | 5.90e-06 | 2 | 85 | 2 | 12097499 | |
| Pubmed | Structural basis for the ATP-induced isomerization of kinesin. | 5.90e-06 | 2 | 85 | 2 | 23500491 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12649170 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8975702 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 25406312 | ||
| Pubmed | Binding of murine leukemia virus Gag polyproteins to KIF4, a microtubule-based motor protein. | 5.90e-06 | 2 | 85 | 2 | 9658142 | |
| Pubmed | 6.28e-06 | 15 | 85 | 3 | 11804779 | ||
| Pubmed | Creb5 coordinates synovial joint formation with the genesis of articular cartilage. | 1.33e-05 | 19 | 85 | 3 | 36435829 | |
| Pubmed | A single cell transcriptional atlas of early synovial joint development. | 1.56e-05 | 20 | 85 | 3 | 32580935 | |
| Pubmed | NELL2-Robo3 complex structure reveals mechanisms of receptor activation for axon guidance. | 1.77e-05 | 3 | 85 | 2 | 32198364 | |
| Pubmed | CCN2 enhances RANKL-induced osteoclast differentiation via direct binding to RANK and OPG. | 1.77e-05 | 3 | 85 | 2 | 25554597 | |
| Pubmed | Correlated expression of Fas, NF-kappaB, and VEGF-C in infiltrating ductal carcinoma of the breast. | 1.77e-05 | 3 | 85 | 2 | 23327061 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 15009103 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 23631855 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 9813312 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 16890532 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 16840550 | ||
| Pubmed | KIF4 mediates anterograde translocation and positioning of ribosomal constituents to axons. | 1.77e-05 | 3 | 85 | 2 | 19158085 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 8670066 | ||
| Pubmed | Identification of the human homologue of mouse KIF4, a kinesin superfamily motor protein. | 1.77e-05 | 3 | 85 | 2 | 10978527 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 23350126 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 34238763 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 26806019 | ||
| Pubmed | Iron-dependent epigenetic modulation promotes pathogenic T cell differentiation in lupus. | 1.77e-05 | 3 | 85 | 2 | 35499082 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 10364234 | ||
| Pubmed | Intraislet SLIT-ROBO signaling is required for beta-cell survival and potentiates insulin secretion. | 1.77e-05 | 3 | 85 | 2 | 24065825 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 19910455 | ||
| Pubmed | Slit-mediated repulsion is a key regulator of motor axon pathfinding in the hindbrain. | 1.77e-05 | 3 | 85 | 2 | 16162649 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 9689915 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 15043778 | ||
| Pubmed | Robo2 contains a cryptic binding site for neural EGFL-like (NELL) protein 1/2. | 1.77e-05 | 3 | 85 | 2 | 30700556 | |
| Pubmed | A molecular mechanism for the heparan sulfate dependence of slit-robo signaling. | 1.77e-05 | 3 | 85 | 2 | 17062560 | |
| Pubmed | Conserved modularity and potential for alternate splicing in mouse and human Slit genes. | 1.77e-05 | 3 | 85 | 2 | 12141424 | |
| Pubmed | Nell-1 induces acrania-like cranioskeletal deformities during mouse embryonic development. | 1.77e-05 | 3 | 85 | 2 | 16652108 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 25850729 | ||
| Pubmed | KIF4 motor regulates activity-dependent neuronal survival by suppressing PARP-1 enzymatic activity. | 1.77e-05 | 3 | 85 | 2 | 16630823 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 12324452 | ||
| Pubmed | Conformational Change of the Hairpin-like-structured Robo2 Ectodomain Allows NELL1/2 Binding. | 1.77e-05 | 3 | 85 | 2 | 35940226 | |
| Pubmed | Maturation of HIV envelope glycoprotein precursors by cellular endoproteases. | 1.77e-05 | 3 | 85 | 2 | 11063880 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 35579738 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 21282654 | ||
| Pubmed | Association of ADAMDEC1 haplotype with high factor VIII levels in venous thromboembolism. | 1.77e-05 | 3 | 85 | 2 | 18449420 | |
| Pubmed | New neurons follow the flow of cerebrospinal fluid in the adult brain. | 1.77e-05 | 3 | 85 | 2 | 16410488 | |
| Pubmed | 1.89e-05 | 64 | 85 | 4 | 22261194 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 2.09e-05 | 135 | 85 | 5 | 28675934 | |
| Pubmed | New genetic associations detected in a host response study to hepatitis B vaccine. | 3.33e-05 | 824 | 85 | 10 | 20237496 | |
| Pubmed | CDMP1/GDF5 has specific processing requirements that restrict its action to joint surfaces. | 3.53e-05 | 4 | 85 | 2 | 16829522 | |
| Pubmed | Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. | 3.53e-05 | 4 | 85 | 2 | 9684805 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 12787574 | ||
| Pubmed | Contralateral migration of oculomotor neurons is regulated by Slit/Robo signaling. | 3.53e-05 | 4 | 85 | 2 | 27770832 | |
| Pubmed | Slits contribute to the guidance of retinal ganglion cell axons in the mammalian optic tract. | 3.53e-05 | 4 | 85 | 2 | 16828733 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 18684836 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 23708002 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 28125646 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 18250426 | ||
| Pubmed | Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects. | 3.53e-05 | 4 | 85 | 2 | 19275959 | |
| Pubmed | Retroviral envelope glycoprotein processing: structural investigation of the cleavage site. | 3.53e-05 | 4 | 85 | 2 | 9521771 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 28463604 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 20004937 | ||
| Pubmed | Characterization of a family of novel cysteine- serine-rich nuclear proteins (CSRNP). | 3.53e-05 | 4 | 85 | 2 | 17726538 | |
| Pubmed | Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. | 3.53e-05 | 4 | 85 | 2 | 8615794 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 30881290 | ||
| Pubmed | Multiple roles for slits in the control of cell migration in the rostral migratory stream. | 3.53e-05 | 4 | 85 | 2 | 14960623 | |
| Interaction | CACNA1A interactions | 5.68e-11 | 123 | 80 | 10 | int:CACNA1A | |
| Interaction | HOXA1 interactions | PLSCR4 PCSK5 SLIT2 NELL1 SPRY3 NELL2 CHRDL2 MEGF8 SLIT1 GRN VWCE AGRN | 1.57e-08 | 356 | 80 | 12 | int:HOXA1 |
| Interaction | IGFL3 interactions | 5.24e-07 | 75 | 80 | 6 | int:IGFL3 | |
| Interaction | ATN1 interactions | 7.75e-07 | 187 | 80 | 8 | int:ATN1 | |
| Interaction | SLURP1 interactions | 1.69e-06 | 144 | 80 | 7 | int:SLURP1 | |
| Interaction | ATXN7 interactions | 4.73e-06 | 109 | 80 | 6 | int:ATXN7 | |
| Interaction | FBXO2 interactions | 5.15e-06 | 411 | 80 | 10 | int:FBXO2 | |
| Interaction | EGFL7 interactions | 1.37e-05 | 77 | 80 | 5 | int:EGFL7 | |
| Interaction | ZFP41 interactions | 7.75e-05 | 57 | 80 | 4 | int:ZFP41 | |
| Interaction | PLA2G10 interactions | 8.72e-05 | 113 | 80 | 5 | int:PLA2G10 | |
| Interaction | CFC1 interactions | 1.46e-04 | 126 | 80 | 5 | int:CFC1 | |
| Interaction | DNAJB9 interactions | 1.53e-04 | 202 | 80 | 6 | int:DNAJB9 | |
| Interaction | NICOL1 interactions | 1.54e-04 | 5 | 80 | 2 | int:NICOL1 | |
| Interaction | ST14 interactions | 1.74e-04 | 207 | 80 | 6 | int:ST14 | |
| Interaction | GFI1B interactions | 2.08e-04 | 136 | 80 | 5 | int:GFI1B | |
| GeneFamily | CD molecules|Integrin beta subunits | 2.73e-06 | 9 | 59 | 3 | 1159 | |
| GeneFamily | WAP four-disulfide core domain containing|Fibronectin type III domain containing | 2.60e-05 | 18 | 59 | 3 | 361 | |
| GeneFamily | VEGF family | 1.04e-04 | 5 | 59 | 2 | 1267 | |
| GeneFamily | Proprotein convertase subtilisin/kexin family | 3.71e-04 | 9 | 59 | 2 | 973 | |
| GeneFamily | Collagens | 4.53e-04 | 46 | 59 | 3 | 490 | |
| GeneFamily | Zinc fingers CXXC-type | 6.77e-04 | 12 | 59 | 2 | 136 | |
| GeneFamily | Ring finger proteins | 2.01e-03 | 275 | 59 | 5 | 58 | |
| GeneFamily | DNA polymerases | 2.53e-03 | 23 | 59 | 2 | 535 | |
| GeneFamily | PRAME family | 2.76e-03 | 24 | 59 | 2 | 686 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.49e-03 | 27 | 59 | 2 | 47 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 4.02e-03 | 29 | 59 | 2 | 782 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.49e-03 | 34 | 59 | 2 | 487 | |
| GeneFamily | Complement system|Sushi domain containing | 6.14e-03 | 36 | 59 | 2 | 492 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 9.15e-03 | 394 | 59 | 5 | 471 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 9.88e-03 | 46 | 59 | 2 | 622 | |
| Coexpression | NABA_MATRISOME | VEGFC COL2A1 PCSK5 SLIT2 NELL1 COL6A3 NELL2 CHRDL2 MEGF8 ADAMDEC1 OTOGL ADAM20 PCSK6 WFIKKN2 SLIT1 LAMA2 COL6A5 PLAT CCN2 NYX ADAM32 TECTA VWCE MUC2 PRG4 AGRN EGFL6 VEGFB | 3.24e-19 | 1008 | 84 | 28 | MM17056 |
| Coexpression | NABA_MATRISOME | VEGFC COL2A1 PCSK5 SLIT2 NELL1 COL6A3 NELL2 CHRDL2 MEGF8 ADAMDEC1 ADAM20 PCSK6 WFIKKN2 SLIT1 LAMA2 COL6A5 PLAT CCN2 NYX ADAM32 TECTA VWCE MUC2 PRG4 AGRN EGFL6 VEGFB | 6.40e-18 | 1026 | 84 | 27 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 SLIT2 NELL1 COL6A3 NELL2 OTOGL SLIT1 LAMA2 COL6A5 CCN2 NYX TECTA VWCE PRG4 AGRN | 8.29e-15 | 270 | 84 | 15 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 SLIT2 NELL1 COL6A3 NELL2 SLIT1 LAMA2 COL6A5 CCN2 NYX TECTA VWCE PRG4 AGRN | 2.32e-13 | 275 | 84 | 14 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.77e-10 | 191 | 84 | 10 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.38e-08 | 196 | 84 | 9 | M3008 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | VEGFC PCSK5 CHRDL2 MEGF8 ADAMDEC1 ADAM20 PCSK6 WFIKKN2 PLAT ADAM32 MUC2 EGFL6 VEGFB | 6.26e-07 | 738 | 84 | 13 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | VEGFC PCSK5 CHRDL2 MEGF8 ADAMDEC1 ADAM20 PCSK6 WFIKKN2 PLAT ADAM32 MUC2 EGFL6 VEGFB | 7.61e-07 | 751 | 84 | 13 | M5885 |
| Coexpression | TSAI_RESPONSE_TO_RADIATION_THERAPY | 3.30e-06 | 32 | 84 | 4 | M308 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 8.21e-06 | 40 | 84 | 4 | M5887 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 2.11e-05 | 261 | 84 | 7 | M1834 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 4.54e-05 | 200 | 84 | 6 | M5930 | |
| Coexpression | GENTILE_UV_LOW_DOSE_DN | 5.39e-05 | 64 | 84 | 4 | M4594 | |
| Coexpression | MEL18_DN.V1_UP | 9.21e-05 | 141 | 84 | 5 | M2784 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED | 1.09e-04 | 29 | 84 | 3 | M47987 | |
| Coexpression | BMI1_DN.V1_UP | 1.12e-04 | 147 | 84 | 5 | M2782 | |
| Coexpression | NABA_ECM_REGULATORS | 1.18e-04 | 238 | 84 | 6 | M3468 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | 1.24e-04 | 240 | 84 | 6 | MM976 | |
| Coexpression | NABA_ECM_REGULATORS | 1.30e-04 | 242 | 84 | 6 | MM17062 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | 1.48e-04 | 156 | 84 | 5 | MM550 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | VEGFC PLSCR4 SLIT2 COL6A3 CHRDL2 CSRNP3 ADAMDEC1 OTOGL PCSK6 CCN2 | 1.70e-04 | 767 | 84 | 10 | M39209 |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL | 1.87e-04 | 164 | 84 | 5 | M41676 | |
| Coexpression | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS | 2.28e-04 | 37 | 84 | 3 | M5040 | |
| ToppCell | Endothelial-A-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.89e-09 | 190 | 84 | 8 | 6e83fa0eb8cabe0ffb35375f16e6bf3755ec4977 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.01e-09 | 191 | 84 | 8 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.01e-09 | 191 | 84 | 8 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 4.33e-09 | 200 | 84 | 8 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.37e-08 | 176 | 84 | 7 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.15e-08 | 185 | 84 | 7 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.62e-08 | 187 | 84 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.86e-08 | 188 | 84 | 7 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.38e-08 | 190 | 84 | 7 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.65e-08 | 191 | 84 | 7 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.12e-08 | 196 | 84 | 7 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.12e-08 | 196 | 84 | 7 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.44e-08 | 197 | 84 | 7 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.44e-08 | 197 | 84 | 7 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | COPD-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 9.78e-08 | 198 | 84 | 7 | 2f13c0b3372af53d1bd85f9546f315c878580a71 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 9.78e-08 | 198 | 84 | 7 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-08 | 198 | 84 | 7 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | COPD-Stromal-Fibroblast|COPD / Disease state, Lineage and Cell class | 9.78e-08 | 198 | 84 | 7 | 7904af61473cb20064f7a3a1e1bfe8d5913cf317 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.78e-08 | 198 | 84 | 7 | aae663c6da70b6e716edeed50cc7d3962d78e697 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.01e-07 | 199 | 84 | 7 | f19c683f38bca3bfee40396f27423441051dec67 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.05e-07 | 200 | 84 | 7 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-07 | 200 | 84 | 7 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.05e-07 | 200 | 84 | 7 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.05e-07 | 200 | 84 | 7 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-8|TCGA-Thymus / Sample_Type by Project: Shred V9 | 4.24e-07 | 151 | 84 | 6 | 5906562efd36fbcb91f96e0a0d3a8fe999ba1e79 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.17e-07 | 161 | 84 | 6 | 048b7dc00746987a24bf870d4d278c4183eb04a2 | |
| ToppCell | -Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 8.20e-07 | 169 | 84 | 6 | 8ebe9a88111c53a09c25a7b6a164a0a17880458d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-06 | 177 | 84 | 6 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-06 | 177 | 84 | 6 | ac90e4ce5be304a5a7473736397327010f2d1999 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-06 | 177 | 84 | 6 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-06 | 183 | 84 | 6 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.39e-06 | 185 | 84 | 6 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.52e-06 | 188 | 84 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.57e-06 | 189 | 84 | 6 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.67e-06 | 191 | 84 | 6 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.67e-06 | 191 | 84 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.67e-06 | 191 | 84 | 6 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-06 | 192 | 84 | 6 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-06 | 192 | 84 | 6 | 144503af50274eaed5cf6effa892c640eab28663 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-06 | 192 | 84 | 6 | c96736bb3a6bb052678b1b078f7823063ca69e6d | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.83e-06 | 194 | 84 | 6 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.83e-06 | 194 | 84 | 6 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.83e-06 | 194 | 84 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.88e-06 | 195 | 84 | 6 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.88e-06 | 195 | 84 | 6 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | IPF-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 1.88e-06 | 195 | 84 | 6 | 9c32756edb54f0c211185d9a98073fe01fd1526a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-06 | 195 | 84 | 6 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-06 | 195 | 84 | 6 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.88e-06 | 195 | 84 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | IPF-Stromal-Fibroblast|IPF / Disease state, Lineage and Cell class | 1.94e-06 | 196 | 84 | 6 | f7ae604ba32b322d86d68b2b54892e7c6ab06c49 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-06 | 196 | 84 | 6 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-06 | 198 | 84 | 6 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | Control-Stromal|Control / Disease state, Lineage and Cell class | 2.06e-06 | 198 | 84 | 6 | ae726b6b7f0a4107899be4d32ac256ffa0bd8d59 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-06 | 198 | 84 | 6 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.06e-06 | 198 | 84 | 6 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.06e-06 | 198 | 84 | 6 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.12e-06 | 199 | 84 | 6 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 2.12e-06 | 199 | 84 | 6 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-06 | 199 | 84 | 6 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.12e-06 | 199 | 84 | 6 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.12e-06 | 199 | 84 | 6 | 3d8c76e3d05acf72a35ca755b51579fc3ae63562 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.12e-06 | 199 | 84 | 6 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.12e-06 | 199 | 84 | 6 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.12e-06 | 199 | 84 | 6 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.12e-06 | 199 | 84 | 6 | fb580e9321ddf97c73b2e356cd82523db74a38a2 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.12e-06 | 199 | 84 | 6 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | (5)_Fibroblast-D|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.12e-06 | 199 | 84 | 6 | 3f415620ad8b8d8c6871e1353e13f87b281fcc0e | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.18e-06 | 200 | 84 | 6 | 01522ed0b68614b1ebdf190957d44a9d48a6c6e3 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.18e-06 | 200 | 84 | 6 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-4|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.18e-06 | 200 | 84 | 6 | 54b18c92daaa3b3368c0c46134b0c27e10c8dbb0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.18e-06 | 200 | 84 | 6 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | 356C-Fibroblasts|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.18e-06 | 200 | 84 | 6 | 9c95329f0b26ff378de803030d4c28517b3adc85 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.18e-06 | 200 | 84 | 6 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-05 | 162 | 84 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 165 | 84 | 5 | 0edd56e8d14eaeced9882dd9206ea93e8f402e8d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 165 | 84 | 5 | fa3aadfff6fb1e7f142db333c60c2cba02b17e6c | |
| ToppCell | facs-Trachea-nan-18m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 167 | 84 | 5 | 7b1fd19946cee67dae68f0f0d98420abcd532482 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-05 | 171 | 84 | 5 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-05 | 171 | 84 | 5 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.86e-05 | 172 | 84 | 5 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.86e-05 | 172 | 84 | 5 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.97e-05 | 174 | 84 | 5 | bc978a2148a0261a4f9d1ca5479b707e224566be | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB|TCGA-Thymus / Sample_Type by Project: Shred V9 | 2.02e-05 | 175 | 84 | 5 | 50f9b994bdd389158f92f891944ea81b2fb15eef | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-05 | 176 | 84 | 5 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-05 | 176 | 84 | 5 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 177 | 84 | 5 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-05 | 177 | 84 | 5 | 921783ed0fe20294d2f384d9136924b679df01bb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 177 | 84 | 5 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | IIH-matDC|IIH / Condition, Cell_class and T cell subcluster | 2.26e-05 | 179 | 84 | 5 | 5999c85ce3bab5309ff1ed154be7e32b037750b1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.26e-05 | 179 | 84 | 5 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.26e-05 | 179 | 84 | 5 | 065a50952e8703fa07767beb6b73a090bf378ca6 | |
| ToppCell | Endothelial-A-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.26e-05 | 179 | 84 | 5 | 138fd6ba6bdbd0ad01c574168addf720b67a0fea | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.26e-05 | 179 | 84 | 5 | 445eeb0356d9fd894aa33dd9f45d893b21424149 | |
| ToppCell | IIH-matDC-|IIH / Condition, Cell_class and T cell subcluster | 2.26e-05 | 179 | 84 | 5 | 46074b2781ed79e2979428b3ec81504621d3903c | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-05 | 180 | 84 | 5 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-05 | 180 | 84 | 5 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-05 | 180 | 84 | 5 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-05 | 181 | 84 | 5 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-05 | 181 | 84 | 5 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 2.38e-05 | 181 | 84 | 5 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| Computational | Adhesion molecules. | 1.41e-05 | 141 | 41 | 6 | MODULE_122 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.70e-05 | 50 | 41 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_METAL_RESPONSE | |
| Drug | DETA | 8.07e-09 | 114 | 82 | 8 | CID000004284 | |
| Drug | LMWH | VEGFC COL2A1 SLIT2 COL6A3 HS6ST2 LAMA2 PLAT CCN2 NYX PRG4 AGRN VEGFB | 4.33e-06 | 663 | 82 | 12 | CID000000772 |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; PC3; HT_HG-U133A | 6.71e-06 | 195 | 82 | 7 | 4467_UP | |
| Drug | Cytarabine | VEGFC PCSK5 SLIT2 WFDC3 COL6A3 NELL2 KMT2A PLAT FAS LRP1B EGFL6 | 9.69e-06 | 598 | 82 | 11 | ctd:D003561 |
| Drug | 1'-acetoxychavicol acetate | 1.90e-05 | 44 | 82 | 4 | CID000119104 | |
| Disease | Congenital myasthenic syndrome ib | 2.17e-05 | 3 | 80 | 2 | C1850792 | |
| Disease | retinoblastoma (is_marker_for) | 4.34e-05 | 4 | 80 | 2 | DOID:768 (is_marker_for) | |
| Disease | Erythema | 4.34e-05 | 4 | 80 | 2 | C0041834 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 1.40e-04 | 37 | 80 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | VEGFC IGF1R SCARF2 OTOGL TENM1 LAMA2 BIRC2 TECTA MAMDC4 SUV39H2 VEGFB | 1.49e-04 | 1074 | 80 | 11 | C0006142 |
| Disease | triglyceride change measurement, response to long-chain n-3 PUFA dietary supplementation | 2.01e-04 | 8 | 80 | 2 | EFO_0007681, EFO_0009308 | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 2.51e-04 | 45 | 80 | 3 | DOID:8947 (biomarker_via_orthology) | |
| Disease | ulcerative colitis (biomarker_via_orthology) | 2.58e-04 | 9 | 80 | 2 | DOID:8577 (biomarker_via_orthology) | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 2.58e-04 | 9 | 80 | 2 | EFO_0009824 | |
| Disease | pancreatic adenocarcinoma (is_marker_for) | 3.22e-04 | 10 | 80 | 2 | DOID:4074 (is_marker_for) | |
| Disease | pneumonia (implicated_via_orthology) | 3.22e-04 | 10 | 80 | 2 | DOID:552 (implicated_via_orthology) | |
| Disease | osteonecrosis (is_implicated_in) | 3.22e-04 | 10 | 80 | 2 | DOID:10159 (is_implicated_in) | |
| Disease | allergic conjunctivitis (is_marker_for) | 3.22e-04 | 10 | 80 | 2 | DOID:11204 (is_marker_for) | |
| Disease | cryptorchidism (biomarker_via_orthology) | 3.93e-04 | 11 | 80 | 2 | DOID:11383 (biomarker_via_orthology) | |
| Disease | Barrett's esophagus (is_marker_for) | 3.93e-04 | 11 | 80 | 2 | DOID:9206 (is_marker_for) | |
| Disease | Small cell carcinoma of lung | 4.31e-04 | 54 | 80 | 3 | C0149925 | |
| Disease | dementia (is_implicated_in) | 4.71e-04 | 12 | 80 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | Respiratory Depression | 5.55e-04 | 13 | 80 | 2 | C0235063 | |
| Disease | Respiratory Insufficiency | 5.55e-04 | 13 | 80 | 2 | C0035229 | |
| Disease | Respiratory Failure | 5.55e-04 | 13 | 80 | 2 | C1145670 | |
| Disease | autoimmune thrombocytopenic purpura (is_marker_for) | 5.55e-04 | 13 | 80 | 2 | DOID:8924 (is_marker_for) | |
| Disease | Graves' disease (is_marker_for) | 7.45e-04 | 15 | 80 | 2 | DOID:12361 (is_marker_for) | |
| Disease | Myopia | 7.45e-04 | 15 | 80 | 2 | C0027092 | |
| Disease | Parkinson's disease (is_marker_for) | 8.11e-04 | 67 | 80 | 3 | DOID:14330 (is_marker_for) | |
| Disease | ovarian cancer (is_marker_for) | 8.47e-04 | 68 | 80 | 3 | DOID:2394 (is_marker_for) | |
| Disease | myopia (is_implicated_in) | 8.50e-04 | 16 | 80 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | response to radiation, Urinary retention | 9.61e-04 | 17 | 80 | 2 | GO_0009314, HP_0000016 | |
| Disease | muscular dystrophy (is_implicated_in) | 9.61e-04 | 17 | 80 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | dermatomyositis (is_marker_for) | 9.61e-04 | 17 | 80 | 2 | DOID:10223 (is_marker_for) | |
| Disease | acute kidney failure (is_marker_for) | 9.61e-04 | 17 | 80 | 2 | DOID:3021 (is_marker_for) | |
| Disease | epilepsy (implicated_via_orthology) | 1.02e-03 | 163 | 80 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Congenital hernia of foramen of Morgagni | 1.20e-03 | 19 | 80 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 1.20e-03 | 19 | 80 | 2 | C0265700 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 1.20e-03 | 19 | 80 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | Lung diseases | 1.26e-03 | 78 | 80 | 3 | C0024115 | |
| Disease | Leukemia, Myelocytic, Acute | 1.28e-03 | 173 | 80 | 4 | C0023467 | |
| Disease | Congenital diaphragmatic hernia | 1.47e-03 | 21 | 80 | 2 | C0235833 | |
| Disease | Behcet Syndrome | 1.93e-03 | 24 | 80 | 2 | C0004943 | |
| Disease | primary biliary cholangitis (is_marker_for) | 2.09e-03 | 25 | 80 | 2 | DOID:12236 (is_marker_for) | |
| Disease | amino acid measurement | 2.44e-03 | 678 | 80 | 7 | EFO_0005134 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 2.50e-03 | 99 | 80 | 3 | DOID:11446 (biomarker_via_orthology) | |
| Disease | Hyperplasia | 2.62e-03 | 28 | 80 | 2 | C0020507 | |
| Disease | chronic obstructive pulmonary disease (biomarker_via_orthology) | 2.62e-03 | 28 | 80 | 2 | DOID:3083 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGQAVCNFVCDCRDC | 31 | Q6UXC1 | |
| GCCVCLSSERFRCPE | 111 | Q5JWF8 | |
| CEATCEPGCKFGECV | 61 | Q8IUX8 | |
| SDSQTCPFCRCEIKG | 381 | Q9ULV8 | |
| CDCGTIRQCAKDPCC | 421 | O43506 | |
| CDPEACACSQAGIKC | 221 | Q9H175 | |
| CCPAGFTCDTQKGTC | 321 | P28799 | |
| CEAETGRCVCPSECV | 546 | O00468 | |
| AQCGPASCCDFRTCV | 411 | Q8TC27 | |
| DPCLRSSDCIEGFCC | 181 | Q9UBU2 | |
| PCRICVCDTGTVLCD | 51 | P02458 | |
| PKDATDRCCVTHDCC | 56 | P14555 | |
| TCEPLTQFVCKSGRC | 966 | Q9NZR2 | |
| CCKECKSICQFQGRT | 326 | Q99435 | |
| VCDCENPTVDLFCCP | 676 | Q99435 | |
| DCGCDCRVFCDPDTC | 211 | Q8WYN3 | |
| CRVFCDPDTCTCSLA | 216 | Q8WYN3 | |
| KRACTENNECCHPEC | 221 | P08069 | |
| CRKCAPNCESCFGSH | 686 | Q92824 | |
| ICERCSSPCRTCEGN | 1276 | Q92824 | |
| TCERCHPTCDQCKGK | 1616 | Q92824 | |
| KVCRRCDENCLSCAG | 896 | P29122 | |
| TCCCFCCPSARQELE | 196 | Q9NRQ2 | |
| EAPGECCKKCEQTHC | 4981 | Q02817 | |
| LDNCRFCPGSQCCVE | 96 | Q9NXJ5 | |
| GKRCVPCKCANHSFC | 616 | Q5VY43 | |
| CGAADCEQCTREGKC | 1996 | Q7Z7M0 | |
| CICKENVEGGDCSRC | 486 | P24043 | |
| PCILCTCEDGRQDCQ | 276 | Q6WN34 | |
| CERFKCPCPTCGTEN | 1276 | P09884 | |
| CKCKNGRVCCSVDFE | 791 | Q92832 | |
| CKTPCERHRDCAECG | 641 | P26010 | |
| PTEECKACTRCGCVT | 791 | Q9Y2X0 | |
| DVCPKTCENFRCLCT | 31 | Q13427 | |
| QKLCCPCCFGRDCLV | 171 | Q9BTU6 | |
| TCVCGRCECTDPRSI | 606 | P26012 | |
| KCRCHPGFEGSACQC | 561 | P05107 | |
| FQQCSLEGKVCVCCP | 126 | P81408 | |
| RKCEKAGCTATCPVC | 51 | Q8NB78 | |
| AKFCGVCTDGRCCTP | 281 | P29279 | |
| IAERTCCCTFCKCPG | 1381 | A8TX70 | |
| EKACCGVPCKCSGQR | 2026 | P12111 | |
| CERCQAKGFVCELCR | 441 | Q6ZN54 | |
| KQKSDCGVDCCCDPT | 1101 | O95239 | |
| CGVDCCCDPTKCRNR | 1106 | O95239 | |
| SDCGVDCSCDPTKCR | 1106 | Q2VIQ3 | |
| CPPACKCVFRDAAQC | 21 | P40197 | |
| CQVPEDCGVCTNCLD | 1161 | Q03164 | |
| CECRVGQKKCTCHRP | 256 | Q96MM7 | |
| CRPCACELEVCAKCG | 86 | Q96MD7 | |
| CLCACPFKFEGIACE | 526 | P02748 | |
| QEEPCCFSPFCVCES | 1996 | Q3ZCN5 | |
| CPAACACSTVERGCS | 31 | Q9GZU5 | |
| CVLCCFSCDSRAQDP | 36 | A0A1B0GVQ0 | |
| LFCEFCDRPVCQDCV | 201 | Q9H8W5 | |
| FRCTECQDIELCPEC | 21 | Q86TJ2 | |
| GCVRRCPCCAVDTTQ | 1171 | Q14524 | |
| CDCKIDPNCDCFSGD | 1471 | Q9UKZ4 | |
| CCPDFKRVCTAELSC | 56 | Q92954 | |
| ICEECGRCKCVPCTA | 146 | O43610 | |
| NDDVKCFCCDGGLRC | 301 | Q13490 | |
| CGSPKECTNLCCEAL | 436 | O15204 | |
| FCQVGCGDRCPSCAK | 1276 | O75443 | |
| CVISRGSPCFCIDVC | 216 | Q495C1 | |
| ILFCTDCCPDCGNRS | 451 | Q5VXH4 | |
| CQVCGKAFDCPSSVR | 451 | Q8TBZ8 | |
| PAEQKCCTTGCGRIC | 51 | Q8IUB2 | |
| PQTDKCCESRCGFVC | 176 | Q8IUA0 | |
| QRPCKECGQACSCLS | 161 | Q15935 | |
| FVCQCPEGFAGKCCE | 106 | P00750 | |
| GKCACECTESPQKCL | 356 | P49767 | |
| PCECSECGKCFRHRT | 556 | Q6P9A3 | |
| CKNCTGCFDRHIPCV | 3086 | O60673 | |
| NDEKVSACCCVPPKC | 116 | A0A1B0GUW6 | |
| KCRCKPNFFCNSTVC | 126 | P25445 | |
| CSENEVCVRPGECRC | 86 | Q96GP6 | |
| CSCTDCFFQKCCPAE | 191 | Q9H5I1 | |
| ILFCTDCCPDCGNRS | 451 | Q5TYX0 | |
| CVCLAGNVSCISPEC | 466 | Q96DN2 | |
| PCTRCTCQLGEVSCE | 706 | Q96DN2 | |
| CPEKCRCEGTTVDCS | 506 | O94813 | |
| EPCRRLENCGACTSC | 61 | O43151 | |
| CCEVCEAPAERVCAA | 16 | Q9H0C1 | |
| SCVTVQRCGGCCPDD | 71 | P49765 | |
| FCCCICGFESTSKEN | 911 | Q8TCN5 | |
| EKNCVCSECGKAFRC | 171 | P17031 | |
| CSFKDCCPRGDCRIS | 106 | Q9H497 | |
| ECNSDVVCPHKCRCE | 506 | O75093 | |
| TAIGQEQCCPICCSE | 626 | O43164 | |
| SQDCECCRRNTECAP | 121 | Q9Y6Q6 | |
| FCSDRCVEACECNPG | 1451 | Q9Y493 | |
| RDCPKALPCAESCEC | 1836 | Q9Y493 | |
| EKCCPNVCGTKSCVA | 76 | Q8TEU8 |